David Gunn
Impact in
- Organic Chemistry top 5%
- Synthesis and Biological Evaluation
- Sulfur-Based Synthesis Techniques
- Catalytic C–H Functionalization Methods
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Nicotinic Acetylcholine Receptors Study 8
-
- Cholinesterase and Neurodegenerative Diseases 6
- Synthesis of Organic Compounds 2
- Co-authors
- Martin H. Osterhout (1 shared paper)Albert Padwa (1 shared paper)Nan‐Horng Lin (6 shared papers)James P. Sullivan (8 shared papers)Stephen P. Arnerić (8 shared papers)Mark W. Holladay (7 shared papers)Peter Mansell (1 shared paper)Diana L. Donnelly‐Roberts (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Gut (2 papers)Synthesis (1 paper)Diabetic Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
David Gunn
25 papers receiving 919 citations
Peers
Comparison fields: 5 of 83
- Organic Chemistry 435
- Pharmacology 159
- Gastroenterology 45
- Molecular Biology 469
- Pharmaceutical Science 28
Countries citing papers authored by David Gunn
This map shows the geographic impact of David Gunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gunn more than expected).
Fields of papers citing papers by David Gunn
This network shows the impact of papers produced by David Gunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gunn. The network helps show where David Gunn may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 206 | |
| 2 | 1996 | 199 | |
| 3 | 1997 | 115 | |
| 4 | 1997 | 70 | |
| 5 | 2011 | 47 | |
| 6 | 1997 | 45 | |
| 7 | 2021 | 37 | |
| 8 | 1998 | 35 | |
| 9 | 2019 | 29 | |
| 10 | 2000 | 29 | |
| 11 | 2000 | 25 | |
| 12 | 2022 | 22 | |
| 13 | 2002 | 18 | |
| 14 | 1996 | 18 | |
| 15 | 2020 | 17 | |
| 16 | 1999 | 12 | |
| 17 | 1996 | 8 | |
| 18 | 1998 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 1996 | 4 |
About David Gunn
David Gunn is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 953 indexed citations. Recurring topics across this work include Nicotinic Acetylcholine Receptors Study (8 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Chemical synthesis and alkaloids (3 papers), Synthesis and Biological Evaluation (3 papers), Synthesis of Organic Compounds (2 papers), Diabetes Management and Research (1 paper), Organic and Inorganic Chemical Reactions (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Organic Chemistry (435 citations), Pharmacology (159 citations), Gastroenterology (45 citations), Molecular Biology (469 citations) and Pharmaceutical Science (28 citations). David Gunn has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Martin H. Osterhout, Albert Padwa, Nan‐Horng Lin, James P. Sullivan, Stephen P. Arnerić, Mark W. Holladay, Peter Mansell, Diana L. Donnelly‐Roberts, David S. Garvey and Janet Sredy. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Gut, Synthesis and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.